PGL 0.00% 85.0¢ prospa group limited.

going backwards..., page-7

  1. 2,620 Posts.
    Hi Tokyo Jo

    Could you please let me know who the author of that report "ecg" is? And secondly, perhaps you could assist with a reference to somewhere I could research the P factor the report refers to. I understand the observations about limitations of the value of the study given the low number of "events" of recurrence. But I do not understand the link between P factor and future Phase 3 trial.

    regards
    DF
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.